Sporadic paraganglioma

World Journal of Surgery

Volumn 32, Issue 5, 2008, Pages 683-687

  Lee, James A ^a   Duh, Quan Yang ^b  

^a NewYork Presbyterian Hospital   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CREATININE; METADRENALIN;

ADRENALIN BLOOD LEVEL; CANCER SURGERY; CATECHOLAMINE RELEASE; CHROMATOGRAPHY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; DRUG URINE LEVEL; FAMILIAL CANCER; FLUOROMETER; FOLLOW UP; GENE; GENE MUTATION; GENETIC PROCEDURES; HUMAN; LABORATORY DIAGNOSIS; LAPAROSCOPIC SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; REVIEW; SCREENING; SDHB GENE; SDHD GENE; SENSITIVITY AND SPECIFICITY; SPORADIC PARAGANGLIOMA; TREATMENT INDICATION; TUMOR LOCALIZATION;

ADRENAL GLAND NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; PARAGANGLIOMA;

EID: 42449105638     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9360-4     Document Type: Review

References (35)

1. Erickson D, Kudva YC, Ebersold MJ, et al. (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86(11):5210-5216
2. Whalen RK, Althausen AF, Daniels GH (1992) Extra-adrenal pheochromocytoma. J Urol 147(1):1-10
3. Young WF Jr (2006) Paragangliomas: clinical overview. Ann N Y Acad Sci 1073:21-29
4. Elder EE, Elder G, Larsson C (2005) Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 89(3):193-201
5. Plouin PF, Gimenez-Roqueplo AP (2006) Pheochromocytomas and secreting paragangliomas. Orphanet J Rare Dis 1(1):49
6. Sclafani LM, Woodruff JM, Brennan MF (1990) Extraadrenal retroperitoneal paragangliomas: natural history and response to treatment. Surgery 108(6):1124-1129; discussion 9-30
7. Gifford RW Jr, Manger WM, Bravo EL (1994) Pheochromocytoma. Endocrinol Metab Clin North Am 23(2):387-404
8. Mantero F, Albiger N (2004) A comprehensive approach to adrenal incidentalomas. Arq Bras Endocrinol Metabol 48(5):583-591
9. Ogawa J, Inoue H, Koide S, et al. (1982) Functioning paraganglioma in the posterior mediastinum. Ann Thorac Surg 33(5):507-510
10. Plouin PF, Duclos JM, Menard J, et al. (1981) Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. Br Med J (Clin Res Ed) 282(6267):853-854
11. Leestma JE, Price EB Jr (1971) Paraganglioma of the urinary bladder. Cancer 28(4):1063-1073
12. Bravo EL, Tagle R (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24(4):539-553
13. Bravo EL, Tarazi RC, Gifford RW, et al. (1979) Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med 301(13):682-686
14. Kudva YC, Sawka AM, Young WF Jr (2003) Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab 88(10):4533-4539
15. Sawka AM, Jaeschke R, Singh RJ, et al. (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88(2):553-558
16. Lenders JW, Eisenhofer G, Armando I, et al. (1993) Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem 39(1):97-103
17. Lenders JW, Keiser HR, Goldstein DS, et al. (1995) Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med 123(2):101-109
18. Lee JA Zarnegar R, Shen WT, et al. (2007) Adrenal incidentaloma, borderline elevations of urine or plasma metanephrines and the "subclinical" pheochromocytoma. Arch Surg 142(9):870-873; discussion 73-74
19. Hsiao RJ, Parmer RJ, Takiyyuddin MA, et al. (1991) Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine 70(1):33-45
20. Young WF Jr (1997) Phaeochromocytoma: how to catch a moonbeam in your hand. Eur J Endocrinol 136(1):28-29
21. Manger WM, Eisenhofer G (2004) Pheochromocytoma: diagnosis and management update. Curr Hypertens Rep 6(6):477-484
22. Pacak K, Eisenhofer G, Ilias I (2004) Diagnostic imaging of pheochromocytoma. Front Horm Res 31:107-120
23. Quint LE, Glazer GM, Francis IR, et al. (1987) Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology 165(1):89-93
24. Bessell-Browne R, O'Malley ME (2007) CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol 188(4):970-974
25. Mukherjee JJ, Peppercorn PD, Reznek RH, et al. (1997) Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 202(1):227-231
26. Francis IR, Korobkin M (1996) Pheochromocytoma. Radiol Clin North Am 4(6):1101-1112
27. Honigschnabl S, Gallo S, Niederle B, et al. (2002) How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 41(2):113-122
28. Timmers HJ, Kozupa A, Chen CC, et al. (2007) Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25(16):2262-2269
29. Ilias I, Pacak K (2004) Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89(2):479-491
30. Elgazzar AH, Gelfand MJ, Washburn LC, et al. (1995) I-123 MIBG scintigraphy in adults. A report of clinical experience. Clin Nucl Med 20(2):147-152
31. Pacak K, Eisenhofer G, Ahlman H, et al. (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium, October 2005. Nat Clin Pract Endocrinol Metab 3(2):92-102
32. Grufferman S, Gillman MW, Pasternak LR, et al. (1980) Familial carotid body tumors: case report and epidemiologic review. Cancer 46(9):2116-2122
33. Amar L, Bertherat J, Baudin E, et al. (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23(34):8812-8818
34. Neumann HP, Bausch B, McWhinney SR, et al. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346(19):1459-1466
35. Neumann HP, Pawlu C, Peczkowska M, et al. (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292(8):943-951